Clinical Trial Update: Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated acetazolamide for preventing altitude-related illness in patients with chronic obstructive pulmonary disease. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED